Results 11 to 20 of about 3,173,890 (267)

Inhibition of Hepatic Acetyl Coenzyme A Carboxylase by Hypolipidemic Agents

open access: hybridJournal of Biological Chemistry, 1969
Abstract The effects of two hypolipidemic agents, 2-methyl-2-[p-(1,2,3,4-tetrahydro-1-naphthyl)-phenoxy]propionate and ethyl 2-(p-chlorophenyl)-2-methylpropionate, on the activity of a highly purified preparation of acetyl coenzyme A carboxylase, obtained from chicken livers, were studied.
Michael E. Maragoudakis
openalex   +4 more sources

Study of drug utilization, morbidity pattern and cost of hypolipidemic agents in a tertiary care hospital

open access: bronze, 2013
Background: Data on the extent of use and costs of lipid-lowering agents are not widely available. Our aim was to study the drug utilization and morbidity pattern, cost of different hypolipidemic drugs along with the risk assessment for coronary heart ...
Kamlesh Patel   +5 more
openalex   +3 more sources

Antihyperglycemic and Hypolipidemic Activities of Flavonoids Isolated from Smilax Dominguensis Mediated by Peroxisome Proliferator-Activated Receptors [PDF]

open access: yesPharmaceuticals
Background/objetives: Mexican people use Smilax dominguensis as a traditional medicine for diabetes control. Some reports have shown an anti-hyperglycemic effect in animal models.
Erandi Ortiz-Barragán   +9 more
doaj   +2 more sources

New compounds with a dihydropyridine framework as promising hypolipidemic and hepatoprotective agents

open access: diamondResearch Results in Pharmacology
Introduction: To solve the problem of complex and safe pharmacological correction of metabolic disorders, including hyperlipidemia, hyperglycemia, and liver lesions is currently very important. With this in mind, the new derivatives of cyanothioacetamide
Elena S. Ketova   +3 more
doaj   +2 more sources

A Proof-of-Concept for a Hypolipidemic Brown Trout Model [PDF]

open access: yesToxics
The impacts of hypolipidemic pharmaceuticals on fish lipid metabolism remain unexplored. However, data points to similar effects and mechanisms of action between fish and humans.
Tiago Lourenço   +4 more
doaj   +2 more sources

Enhanced Myopathy Following Administration of Hypolipidemic Agents under Urethane Anesthesia.

open access: bronzeBiological and Pharmaceutical Bulletin, 1997
The enhanced effect of urethane anesthesia on the serum creatine kinase (CPK) level following administration of hypolipidemic agents was examined to develop a convenient experimental screening method for drug-induced myopathy.
Aki NAKAI   +4 more
openalex   +3 more sources

Are We Using Ezetimibe As Much As We Should? [PDF]

open access: yesBiomarker Insights
Lipid-lowering therapies, particularly non-statin regimens, are underutilized as ~2/3 of patients with atherosclerotic cardiovascular (CV) disease (CVD) are not optimally managed, and do not attain target low-density lipoprotein cholesterol (LDL-C ...
Antonis A Manolis   +3 more
doaj   +2 more sources

Cocos Nucifera Endocarp Extract Exhibits Anti-diabetic and Antilipidemic Activities in Diabetic Rat Model [PDF]

open access: yesInternational Journal of Scientific Research in Dental and Medical Sciences, 2022
Background and aim: The fruits of Cocos nucifera have long been used in traditional medicine as anti-inflammatory, antimicrobial, antiparasitic, anticancer, and cardiotonic.
Farjana Akter   +5 more
doaj   +1 more source

The effect of Elettaria cardamomum (cardamom) on the metabolic syndrome: Narrative review [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2021
Metabolic syndrome (MetS), as a health-threatening factor, consists of various symptoms including insulin resistance, high blood sugar, hypertension, dyslipidemia, inflammation, and abdominal obesity that raise the risk of diabetes mellitus and ...
Roghayeh Yahyazadeh   +4 more
doaj   +1 more source

FINE STRUCTURAL CHANGES IN THE HEPATIC MICROBODIES OF RATS TREATED WITH HYPOLIPIDEMIC AGENTS, GEMFIBROZIL AND CLOFIBRATE

open access: bronze, 1978
Fine structural changes in the hepatic microbodies of male adult rats treated with a newly developed hypolipidemic agent, gemfibrozil, were compared with results of clofibrate treatment.
Kuniaki Fukuda   +3 more
openalex   +3 more sources

Home - About - Disclaimer - Privacy